TCF7L2 and type 2 diabetes mellitus: In 2014, Canivell et al. used a candidate gene approach and compared peripheral blood DNA methylation profiles within the promoter of the TCF7L2 risk gene in newly diagnosed, drug-naïve T2D patients (n = 93) and age- and BMI-matched controls (n = 93).